US FDA refuses to approve first MDMA-based treatment for PTSD
The U.S. FDA has refused to approve a mind-altering MDMA-based therapy for patients with post-traumatic stress disorder, saying it cannot be approved based on the data submitted, developer Lykos Therapeutics said.
POPULAR POSTS
Poland prepares for peaking floods
September 20, 2024
Italy evacuates thousands as Boris hits the north
September 20, 2024
China and the US race to tame nuclear fusion for clean energy
September 20, 2024
LIVE STREAM